Qilian International Holding Group Limited Total Non Current Liabilities 2011-2026 | QLI

Annual Total Non Current Liabilities Qilian International Holding Group Limited

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	1.33 M	1.76 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.76 M	1.33 M	1.54 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Alnylam Pharmaceuticals ALNY	604 M	$ 333.39	-1.77 %	$ 43.7 B	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 3.17	3.93 %	$ 5.22 M	Israel
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.73	3.04 %	$ 8.97 B	Australia
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Aligos Therapeutics ALGS	15 M	$ 7.42	-15.1 %	$ 73.3 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
Amphastar Pharmaceuticals AMPH	69.4 M	$ 21.68	1.4 %	$ 1.01 B	USA
Cabaletta Bio CABA	43.9 M	$ 3.4	4.29 %	$ 342 M	USA
CymaBay Therapeutics CBAY	1.26 M	-	-	$ 3.45 B	USA
BioNTech SE BNTX	341 M	$ 99.47	1.08 %	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
ContraFect Corporation CFRX	9.41 M	-	-5.16 %	$ 5.39 M	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	168 M	-	-	$ 399 M	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	90.3 M	$ 4.24	2.17 %	$ 453 M	USA
Arcutis Biotherapeutics ARQT	167 M	$ 24.58	-2.03 %	$ 3.13 B	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.49	0.68 %	$ 397 M	Britain
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
Checkpoint Therapeutics CKPT	2.47 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	254 K	-	-16.75 %	$ 25.8 M	USA
Celldex Therapeutics CLDX	17.3 M	$ 33.87	1.62 %	$ 2.25 B	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Clearside Biomedical CLSD	4.72 M	-	-	$ 25.3 M	USA
bluebird bio BLUE	219 M	-	-	$ 546 M	USA
AstraZeneca PLC AZN	30.8 B	-	-	$ 96.9 B	Britain
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA